These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 3438942

  • 1. [Use of magnesium oxide and vitamin B6 for the prevention of oxalate urolithiasis].
    Konstantinova OV, Chudnovskaia MV, Ianenko EK, Korolev VV.
    Urol Nefrol (Mosk); 1987; (6):12-5. PubMed ID: 3438942
    [No Abstract] [Full Text] [Related]

  • 2. Formation of calcium oxalate urolithiasis in experiment and its inhibition by pyridoxine and magnesium.
    Krídl J, Zvara V, Revúsová V, Ondrus B.
    Czech Med; 1986; 9(3):124-9. PubMed ID: 3095070
    [Abstract] [Full Text] [Related]

  • 3. [Hydrochlorothiazide, allopurinol and magnesium oxide in the treatment of recurrent calcium urolithiasis].
    Musialik D, Głuszek J, Pieczyńska A.
    Pol Tyg Lek; 1986; 46(40-42):739-42. PubMed ID: 1669148
    [Abstract] [Full Text] [Related]

  • 4. Magnesium oxide-pyridoxine therapy for recurrent calcium oxalate calculi.
    Prien EL, Gershoff SF.
    J Urol; 1974 Oct; 112(4):509-12. PubMed ID: 4414543
    [No Abstract] [Full Text] [Related]

  • 5. [Urine saturation with calcium oxalate in urolithiasis].
    Bogado CE, Zanchetta JR.
    Medicina (B Aires); 1988 Oct; 48(1):39-44. PubMed ID: 3216787
    [No Abstract] [Full Text] [Related]

  • 6. [Studies on the etiology of urolithiasis: effects of vitamin B6 and vitamin B1 on urinary oxalate excretion].
    Yachiku S, Okawa T, Takeuchi M, Sonoda T.
    Hinyokika Kiyo; 1969 May; 15(5):297-303. PubMed ID: 5816782
    [No Abstract] [Full Text] [Related]

  • 7. Importance of magnesium in absorption and excretion of oxalate.
    Zimmermann DJ, Voss S, von Unruh GE, Hesse A.
    Urol Int; 2005 May; 74(3):262-7. PubMed ID: 15812215
    [Abstract] [Full Text] [Related]

  • 8. [Effect of long-term pyridoxine administration on serum and urinary values of calculi-forming substances in Ca-oxalate urolithiasis].
    Revúsová V, Gratzlová J, Zvara V, Krídl J, Suchánek B.
    Vnitr Lek; 1978 May; 24(5):445-50. PubMed ID: 96593
    [No Abstract] [Full Text] [Related]

  • 9. Magnesium oxide-pyridoxine therapy for recurrent urolithiasis.
    Nutr Rev; 1976 Jan; 34(1):18-20. PubMed ID: 765895
    [No Abstract] [Full Text] [Related]

  • 10. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients.
    Murayama T, Sakai N, Yamada T, Takano T.
    Int J Urol; 2001 Oct; 8(10):525-31; discussion 532. PubMed ID: 11737477
    [Abstract] [Full Text] [Related]

  • 11. [Studies on tryptophan metabolism in calcium oxalate urolithiasis].
    Grimm U, Steinhauser I, Wulff K, Knapp A, Zschiesche M.
    Z Urol Nephrol; 1988 May; 81(5):299-303. PubMed ID: 3407338
    [Abstract] [Full Text] [Related]

  • 12. [Current status of prevention and therapy of urinary calculi and peroral chemo-litholysis with special attention to the relationship of increased excretion of uric acid in oxalate lithiasis].
    Leskovar P.
    Z Urol Nephrol; 1980 Mar; 73(3):229-39. PubMed ID: 7434987
    [Abstract] [Full Text] [Related]

  • 13. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B, Rahman MA.
    Biomed Pharmacother; 1986 Mar; 40(3):108-10. PubMed ID: 3742009
    [Abstract] [Full Text] [Related]

  • 14. [Long-term clinical experiences with the cation exchanger UJOLYT as a metaphylactic in absorptive hypercalciuria and chronic recurring calcium oxalate lithiasis].
    Böhm WD.
    Z Urol Nephrol; 1983 Jul; 76(7):445-51. PubMed ID: 6637172
    [Abstract] [Full Text] [Related]

  • 15. Excretion of urinary phosphate and magnesium on three diets in patients with urolithiasis.
    Juuti M, Alhava EM, Lammi S.
    Ann Clin Res; 1981 Feb; 13(1):1-5. PubMed ID: 7247320
    [Abstract] [Full Text] [Related]

  • 16. [Oxalate urolithiasis following intestinal resection and dysfunction].
    Cheng JY, Lin SY.
    Zhonghua Wai Ke Za Zhi; 1985 Aug; 23(8):505-6, 512. PubMed ID: 4092554
    [No Abstract] [Full Text] [Related]

  • 17. Nutritional aspects of urolithiasis.
    Ringsdorf WM, Cheraskin E.
    South Med J; 1981 Jan; 74(1):41-3, 46. PubMed ID: 7006092
    [Abstract] [Full Text] [Related]

  • 18. [Analytical evaluation of urinary calculi mineral composition].
    Machoy P.
    Ann Acad Med Stetin; 1995 Jan; 41():259-71. PubMed ID: 8615550
    [Abstract] [Full Text] [Related]

  • 19. [Studies of influence of animal protein intake on the urinary risk factors of calcium oxalate stone formation].
    Nishii M.
    Hinyokika Kiyo; 1984 Dec; 30(12):1737-47. PubMed ID: 6532203
    [Abstract] [Full Text] [Related]

  • 20. Effect of high and low calcium diets on stone forming risk during liberal oxalate intake.
    Matsumoto ED, Heller HJ, Adams-Huet B, Brinkley LJ, Pak CY, Pearle MS.
    J Urol; 2006 Jul; 176(1):132-6. PubMed ID: 16753387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.